Literature DB >> 20230089

Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis.

Inge Henselmans1, Vicki S Helgeson, Howard Seltman, Jakob de Vries, Robbert Sanderman, Adelita V Ranchor.   

Abstract

OBJECTIVE: In this article, we aim to (a) identify distinct trajectories of psychological distress in the first year after a breast cancer diagnosis in women treated with adjuvant therapy and (b) explore possible predictors of these trajectories, that is, demographic, medical, and personal characteristics.
METHOD: The 171 patients were assessed after diagnosis, after surgery, after adjuvant treatment, in the reentry phase, and in the (short-term) survivorship phase (2 and 6 months after the end of treatment, respectively). MAIN OUTCOME MEASURE: Psychological distress was assessed with the 12-item General Health Questionnaire.
RESULTS: There were four trajectories of distress: a group that experienced no distress (36.3%), a group that experienced distress only in the active treatment phase (33.3%), a group that experienced distress in the reentry and survivorship phase (15.2%), and a group that experienced chronic distress (15.2%). Personality and physical complaints resulting from adjuvant treatment could distinguish the distress trajectories. Mastery was the only unique predictor.
CONCLUSION: Most patients were not distressed in response to breast cancer or only temporarily so. Yet, a minority of patients became or remained distressed after the end of treatment. Copyright 2010 APA, all rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20230089     DOI: 10.1037/a0017806

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  96 in total

1.  Emotional adjustment over 1 year post-diagnosis in patients with cancer: understanding and predicting adjustment trajectories.

Authors:  W Linden; R MacKenzie; K Rnic; C Marshall; A Vodermaier
Journal:  Support Care Cancer       Date:  2014-11-01       Impact factor: 3.603

2.  A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender.

Authors:  Cristiane Decat Bergerot; Hannah-Rose Mitchell; Kimlin Tam Ashing; Youngmee Kim
Journal:  Support Care Cancer       Date:  2017-02-02       Impact factor: 3.603

3.  Do Different Methods for Modeling Age-Graded Trajectories Yield Consistent and Valid Results?

Authors:  John R Warren; Liying Luo; Andrew Halpern-Manners; James M Raymo; Alberto Palloni
Journal:  AJS       Date:  2015-05

4.  How are spousal depressed mood, distress, and quality of life associated with risk of depressed mood in cancer survivors? Longitudinal findings from a national sample.

Authors:  Kristin Litzelman; K Robin Yabroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06       Impact factor: 4.254

5.  Identification of distinct depressive symptom trajectories in women following surgery for breast cancer.

Authors:  Laura B Dunn; Bruce A Cooper; John Neuhaus; Claudia West; Steven Paul; Bradley Aouizerat; Gary Abrams; Janet Edrington; Debby Hamolsky; Christine Miaskowski
Journal:  Health Psychol       Date:  2011-07-04       Impact factor: 4.267

6.  Evaluation of the efficacy and usability of NCI's Facing Forward booklet in the cancer community setting.

Authors:  Joanne S Buzaglo; Suzanne M Miller; Jeffery Kendall; Annette L Stanton; Kuang-Yi Wen; John Scarpato; Fang Zhu; Jennifer Lyle; Julia Rowland
Journal:  J Cancer Surviv       Date:  2012-12-11       Impact factor: 4.442

7.  Distress screening remains important during follow-up after primary breast cancer treatment.

Authors:  Floortje K Ploos van Amstel; Sanne W van den Berg; Hanneke W M van Laarhoven; Marieke F M Gielissen; Judith B Prins; Petronella B Ottevanger
Journal:  Support Care Cancer       Date:  2013-03-01       Impact factor: 3.603

8.  Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.

Authors:  Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-27       Impact factor: 4.254

9.  Cytokine genetic variations and fatigue among patients with breast cancer.

Authors:  Julienne E Bower; Patricia A Ganz; Michael R Irwin; Steven Castellon; Jesusa Arevalo; Steven W Cole
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

10.  Cancer patient and survivor research from the cancer information service research consortium: a preview of three large randomized trials and initial lessons learned.

Authors:  Alfred C Marcus; Michael A Diefenbach; Annette L Stanton; Suzanne M Miller; Linda Fleisher; Peter C Raich; Marion E Morra; Rosemarie Slevin Perocchia; Zung Vu Tran; Mary Anne Bright
Journal:  J Health Commun       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.